Viewing Study NCT03565068


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2025-12-25 @ 3:00 PM
Study NCT ID: NCT03565068
Status: COMPLETED
Last Update Posted: 2021-03-29
First Post: 2018-06-01
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-06-20
Start Date Type: ACTUAL
Primary Completion Date: 2020-04-03
Primary Completion Date Type: ACTUAL
Completion Date: 2020-04-03
Completion Date Type: ACTUAL
First Submit Date: 2018-06-01
First Submit QC Date: None
Study First Post Date: 2018-06-21
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-03-02
Results First Submit QC Date: None
Results First Post Date: 2021-03-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-03-02
Last Update Post Date: 2021-03-29
Last Update Post Date Type: ACTUAL